JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by NEEDLEMAN, P.
Right arrow Articles by JOHNSON, E. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by NEEDLEMAN, P.
Right arrow Articles by JOHNSON, E. M., JR.
Journal of Pharmacology And Experimental Therapeutics, Vol. 184, Issue 3, 709-715, 1973
Copyright © 1973 by American Society for Pharmacology and Experimental Therapeutics


MECHANISM OF TOLERANCE DEVELOPMENT TO ORGANIC NITRATES

PHILIP NEEDLEMAN 1 and EUGENE M. JOHNSON JR. 1

1 The Edward Mallinckrodt Department of Pharmacology, Washington University School of Medicine, St. Louis, Missouri

Tolerance to the vasodilator activity of organic nitrates appears to involve an alteration in a receptor in vascular smooth muscle. An in vitro model of nitrate tolerance was developed by incubation of rabbit thoracic aorta with organic nitrate at alkaline pH, producing a time- and concentration-dependent decrease in sensitivity to glyceryl trinitrate. Cross-tolerance is observed to all organic nitrates studied but not to nonnitrate vasodilators. When aortic strips are incubated at alkaline pH, nitrite formation is enhanced and tissue SH levels decrease. It s proposed that organic nitrate tolerance involves the oxidation of a critical sulfhydryl in the glyceryl trinitrate "receptor." This hypothesis is supported by the reversal of both in vitro- and in vivo-induced glyceryl trinitrate tolerance by the disulfide reducing agent, dithiothreitol.

Submitted on July 20, 1972
Accepted on November 1, 1972




This article has been cited by other articles:


Home page
Circ. Res.Home page
J. S. Stamler
Nitroglycerin-Mediated S-Nitrosylation of Proteins: A Field Comes Full Cycle
Circ. Res., September 12, 2008; 103(6): 557 - 559.
[Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
D. L. Guettler and S.-X. Ma
Effects of Nitric Oxide and Noradrenergic Activation in the Posterior Hypothalamus on Arterial Pressure Tolerance to Nitroglycerin in Rats
Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2008; 13(2): 98 - 106.
[Abstract] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. D. MacPherson, T. D. Gillespie, H. A. Dunkerley, D. H. Maurice, and B. M. Bennett
Inhibition of Phosphodiesterase 5 Selectively Reverses Nitrate Tolerance in the Venous Circulation
J. Pharmacol. Exp. Ther., April 1, 2006; 317(1): 188 - 195.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
T. Kakutani, K. Ogawa, S. Iwahashi, K. Mizumoto, and Y. Hatano
Sevoflurane Enhances Nitroglycerin Tolerance in Rat Aorta: Implications for the Desensitization of Soluble Guanylate Cyclase Possibly Through the Additive Generation of Superoxide Anions and/or Hydroxyl Radicals Within Vascular Smooth Muscle
Anesth. Analg., October 1, 2005; 101(4): 1015 - 1022.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
V. Mollace, C. Muscoli, E. Masini, S. Cuzzocrea, and D. Salvemini
Modulation of Prostaglandin Biosynthesis by Nitric Oxide and Nitric Oxide Donors
Pharmacol. Rev., June 1, 2005; 57(2): 217 - 252.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Li, H. Cui, X. Liu, and J. L. Zweier
Xanthine Oxidase Catalyzes Anaerobic Transformation of Organic Nitrates to Nitric Oxide and Nitrosothiols: CHARACTERIZATION OF THIS MECHANISM AND THE LINK BETWEEN ORGANIC NITRATE AND GUANYLYL CYCLASE ACTIVATION
J. Biol. Chem., April 29, 2005; 280(17): 16594 - 16600.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. DiFabio, Y. Ji, V. Vasiliou, G. R. J. Thatcher, and B. M. Bennett
Role of Mitochondrial Aldehyde Dehydrogenase in Nitrate Tolerance
Mol. Pharmacol., November 1, 2003; 64(5): 1109 - 1116.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Gori and J. D. Parker
Nitrate Tolerance: A Unifying Hypothesis
Circulation, November 5, 2002; 106(19): 2510 - 2513.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Babaei and D. J Stewart
Overexpression of endothelial NO synthase induces angiogenesis in a co-culture model
Cardiovasc Res, July 1, 2002; 55(1): 190 - 200.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. J. Ignarro
After 130 years, the molecular mechanism of action of nitroglycerin is revealed
PNAS, June 11, 2002; 99(12): 7816 - 7817.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. O. Parker, J. D. Parker, R. W. Caldwell, B. Farrell, and W. H. Kaesemeyer
The effect of supplemental L-arginine on tolerance development during continuous transdermal nitroglycerin therapy
J. Am. Coll. Cardiol., April 3, 2002; 39(7): 1199 - 1203.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. D. Parker and T. Gori
Tolerance to the Organic Nitrates: New Ideas, New Mechanisms, Continued Mystery
Circulation, November 6, 2001; 104(19): 2263 - 2265.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
N. Haramaki, H. Ikeda, Y. Takajo, A. Katoh, S. Kanaya, S. Shintani, R. Haramaki, T. Murohara, and T. Imaizumi
Long-Term Smoking Causes Nitroglycerin Resistance in Platelets by Depletion of Intraplatelet Glutathione
Arterioscler. Thromb. Vasc. Biol., November 1, 2001; 21(11): 1852 - 1856.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
U. Jurt, T. Gori, A. Ravandi, S. Babaei, P. Zeman, and J. D. Parker
Differential effects of pentaerythritol tetranitrate and nitroglycerin on the development of tolerance and evidence of lipid peroxidation: a human in vivo study
J. Am. Coll. Cardiol., September 1, 2001; 38(3): 854 - 859.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
T. Yamamoto and R. J. Bing
Nitric Oxide Donors
Experimental Biology and Medicine, December 1, 2000; 225(3): 200 - 206.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
J. D. Ratz, A. B. Fraser, K. J. Rees-Milton, M. A. Adams, and B. M. Bennett
Endothelin Receptor Antagonism Does Not Prevent the Development of In Vivo Glyceryl Trinitrate Tolerance in the Rat
J. Pharmacol. Exp. Ther., November 1, 2000; 295(2): 578 - 585.
[Abstract] [Full Text]


Home page
HypertensionHome page
T. Yamashita, S. Kawashima, Y. Ohashi, M. Ozaki, Y. Rikitake, N. Inoue, K.-i. Hirata, H. Akita, and M. Yokoyama
Mechanisms of Reduced Nitric Oxide/cGMP-Mediated Vasorelaxation in Transgenic Mice Overexpressing Endothelial Nitric Oxide Synthase
Hypertension, July 1, 2000; 36(1): 97 - 102.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. J. Mihm, C. M. Coyle, L. Jing, and J. A. Bauer
Vascular Peroxynitrite Formation during Organic Nitrate Tolerance
J. Pharmacol. Exp. Ther., October 1, 1999; 291(1): 194 - 198.
[Abstract] [Full Text]


Home page
Drug Metab. Dispos.Home page
P. S.-Y. Wong and J. M. Fukuto
Reaction of Organic Nitrate Esters and S-Nitrosothiols With Reduced Flavins: A Possible Mechanism of Bioactivation
Drug Metab. Dispos., April 1, 1999; 27(4): 502 - 509.
[Abstract] [Full Text]


Home page
J Am Coll CardiolHome page
H. Watanabe, M. Kakihana, S. Ohtsuka, and Y. Sugishita
Randomized, double-blind, placebo-controlled study of carvedilol on the prevention of nitrate tolerance in patients with chronic heart failure
J. Am. Coll. Cardiol., November 1, 1998; 32(5): 1194 - 1200.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
H. Watanabe, M. Kakihana, S. Ohtsuka, and Y. Sugishita
Preventive effects of carvedilol on nitrate tolerance--a randomized, double-blind, placebo-controlled comparative study between carvedilol and arotinolol
J. Am. Coll. Cardiol., November 1, 1998; 32(5): 1201 - 1206.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Dikalov, B. Fink, M. Skatchkov, D. Stalleicken, and E. Bassenge
Formation of Reactive Oxygen Species by Pentaerithrityltetranitrate and Glyceryl Trinitrate In Vitro and Development of Nitrate Tolerance
J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 938 - 944.
[Abstract] [Full Text]


Home page
CirculationHome page
H. Watanabe, M. Kakihana, S. Ohtsuka, and Y. Sugishita
Randomized, Double-Blind, Placebo-Controlled Study of Ascorbate on the Preventive Effect of Nitrate Tolerance in Patients With Congestive Heart Failure
Circulation, March 10, 1998; 97(9): 886 - 891.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. C. Docherty and M. R. Maclean
EndothelinB Receptors in Rabbit Pulmonary Resistance Arteries: Effect of Left Ventricular Dysfunction
J. Pharmacol. Exp. Ther., March 1, 1998; 284(3): 895 - 903.
[Abstract] [Full Text]


Home page
NEJMHome page
J. D. Parker and J. O. Parker
Nitrate Therapy for Stable Angina Pectoris
N. Engl. J. Med., February 19, 1998; 338(8): 520 - 531.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
I. J. Kullo, R. S. Schwartz, V. J. Pompili, M. Tsutsui, S. Milstien, L. A. Fitzpatrick, Z. S. Katusic, and T. O'Brien
Expression and Function of Recombinant Endothelial NO Synthase in Coronary Artery Smooth Muscle Cells
Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 2405 - 2412.
[Abstract] [Full Text]


Home page
CirculationHome page
H. Watanabe, M. Kakihana, S. Ohtsuka, and Y. Sugishita
Randomized, Double-Blind, Placebo-Controlled Study of Supplemental Vitamin E on Attenuation of the Development of Nitrate Tolerance
Circulation, October 21, 1997; 96(8): 2545 - 2550.
[Abstract] [Full Text]


Home page
HypertensionHome page
I. J. Kullo, G. Mozes, R. S. Schwartz, P. Gloviczki, M. Tsutsui, Z. S. Katusic, and T. O'Brien
Enhanced Endothelium-Dependent Relaxations After Gene Transfer of Recombinant Endothelial Nitric Oxide Synthase to Rabbit Carotid Arteries
Hypertension, September 1, 1997; 30(3): 314 - 320.
[Abstract] [Full Text]


Home page
J CARDIOVASC PHARMACOL THERHome page
M. Skatchkov, L.L. Larina, A.A. Larin, N. Fink, and E. Bassenge
Urinary Nitrotyrosine Content as a Marker of Peroxynitrite-induced Tolerance to Organic Nitrates
Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1997; 2(2): 85 - 96.
[Abstract] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. A. Bauer, T. Nolan, and H.-L. Fung
Vascular and Hemodynamic Differences between Organic Nitrates and Nitrites
J. Pharmacol. Exp. Ther., January 1, 1997; 280(1): 326 - 331.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1973 by the American Society for Pharmacology and Experimental Therapeutics.